NCT05272865 2023-02-01
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
LaSanta S A S
Phase 1/2 Unknown
Clinical Trials
4 trialsNCT01031953 2017-05-09
Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
OHSU Knight Cancer Institute
Phase 1/2 Terminated
NCT01046240 2015-01-27
Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy
Clinica Universidad de Navarra, Universidad de Navarra
Phase 1/2 Completed
NCT00412425 2012-05-04
Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting
M.D. Anderson Cancer Center
Phase 1/2 Completed